Vnitr Lek 2010, 56(1):8-10

Paraneoplastický tromboembolický syndrom jako první příznak zhoubného onemocnění - editorial

D. Karetová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN Praha, přednosta prof. MUDr. Aleš Linhart, DrSc.

Received: September 29, 2009; Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karetová D. Paraneoplastický tromboembolický syndrom jako první příznak zhoubného onemocnění - editorial. Vnitr Lek. 2010;56(1):8-10.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Carrier M, Le Gal G, Wells PS et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008; 149: 323-333. Go to original source... Go to PubMed...
    2. Piccioli A, Leasing AW, Prins MH et al. SOMIT Investigators Group. Extensive screening for occult malignant disease in idiopathic venous throemboembolism: a prospective randomized clinical trial. J Tromb Haemost 2004; 2: 884-889. Go to original source... Go to PubMed...
    3. Sorensen HT, Mellemkjaer L, Olsen JH et al. Prognosis of cancers associated with venous thromboembolicm. N Engl J Med 2000; 343: 1846-1850. Go to original source... Go to PubMed...
    4. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000; 342: 1953-1958. Go to original source... Go to PubMed...
    5. Kessler P. Prophylaxis and treatment of thromboembolism in oncology. Vnitř Lék 2009; 55: 219-222. Go to PubMed...
    6. Malý R, Vodicková L. The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use? Vnitř Lék 2004; 50: 751-755. Go to PubMed...
    7. Uhrinová A, Gavorník P, Vacula I. Venous thromboembolism in an oncology patient. Vnitř Lék 2009; 55: 599-603. Go to PubMed...
    8. Karetová D. Thrombotic complications in patients with malignant diseases. Vnitř Lék 2000; 46: 715-718. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.